- Meeting abstract
- Open Access
Effectiveness of endovascular thrombolysis in acute mesenteric vein thrombosis
BMC Geriatrics volume 11, Article number: A35 (2011)
Mesenteric vein thrombosis (MVT) is a rare, often lethal, entity that accounts for approximately 10-15% of all cases of mesenteric ischemia [1, 2]. Current indications for surgery in patients with acute MVT include signs of peritonitis, bowel infarction and hemodynamic instability.
In all other cases, long-lasting anticoagulation is the strategy of choice [3, 4], patients with MVT have a fairly good prognosis and long-term outcomes once appropriate anticoagulation is achieved [4, 5]. At variance with the slow onset of recanalization that takes place during anticoagulation, thrombolysis leads to a rapid re-opening of a vessel, with immediate tissue reperfusion .
Materials and methods
We have followed up each for at least 3 years. 32 MVT patients (Table 1), 18 of whom (treated group) had undergone percutaneous transhepatic thrombolysis and mechanical thrombectomy prior to starting long-lasting warfarin treatment. The other 14 patients (control group) received only warfarin treatment. In each case and for each patient, the rate of surgical approach (bowel resection) and the rate of long-term mesenteric-portal hypertension was evaluated.
In 16/18 patients (88.8%) following the percutaneous treatment, flow restoration in the thrombosed mesenteric vein was documented by direct portal venography (Fig. 1). All patients with successfully recanalized MVT did not develop recurrent episodes during the long-lasting (1 year) oral anticoagulation therapy. The 30-day mortality rate was similar in the two groups (p=0.998). Bowel resection was needed in 1 patient (5.5%) in the treated group and in 5 patients (35.7%) in the control group (p=0.022 as to the rate of short-term surgical sequelae). A significant difference was also found as to long-term sequelae, especially portal hypertension (7/14 patients in the control group, 50.0%; 2/18 patients in the treated group, 11.1%; p=0.043) (Fig. 2).
MVT is still a serious disease, with a high mortality rate (25-35%), mostly related to transmural necrosis and bowel perforation due to the delay in diagnosis [1, 6]. In the absence of major clinical signs and symptoms, the severity of bowel ischemia on admission is based on the evaluation of bowel wall thickness by contrast-enhanced CT scan (90% sensitivity). Macroscopically infarcted small bowel without transmural necrosis is potentially reversible with long-lasting anticoagulation [1, 7–10]. Encouraging results of endovascular thrombolytic treatments have been reported in literature [11, 12]. According to our results, when administered promptly, endovascular intervention using percutaneous transhepatic thrombolysis and mechanical thrombectomy appears to have a lower rate of early and late complications compared to warfarin treatment alone.
McManimon S, Ryu RK, Durham JD: Mesenteric Venous Thrombosis. Tech Vasc Interv Radiol. 1998, 1 (4): 209-15. 10.1016/S1089-2516(98)80288-6.
Divino CM, Park IS, Angel LP, et al: A retrospective study of diagnosis and management of mesenteric vein thrombosis. Am J Surg. 2001, 181: 20-3. 10.1016/S0002-9610(00)00532-8.
Hefny AF, et al: Management of mesenteric vascular occlusion. Singapore Med J. 2008, 49 (4): 319-
Kitchens CS: Venous thromboses at unusual sites in consultative hemostasis and thrombosis. Edited by: Alving Kessler, editor. Kitchens. W.B. Saunders Co. 2002, 225-42.
Sreenarasimhaiah Jayaprakash: Diagnosis and management of intestinal ischaemic disorders. BMJ. 2003, 326: 1372-6. 10.1136/bmj.326.7403.1372.
Kumar S, Sarr MG, Kamath PS: Mesenteric venous thrombosis. New Engl J Med. 2001, 345: 1683-8. 10.1056/NEJMra010076.
Morash MD, Ebaugh JL, Chiou AC, Matsumura JS, Pearce WH, Yao JST: Mesenteric venous thrombosis: a changing clinical entity. J Vasc Surg. 2001, 34: 673-9. 10.1067/mva.2001.117331.
Brunaud L, Antunes L, Collinet-Adler S, Marchal F, Ayav A, Bresler L: Acute mesenteric venous thrombosis: Case for nonoperative management. J Vasc Surg. 2001, 34 (4): 673-9. 10.1067/mva.2001.117331.
Grieshop RJ, Dalsing MC, Cikrit DF, Lalka SG, Sawchuk AP: Acute mesenteric venous thrombosis. Revisited in a time of diagnostic clarity. Ann Surg. 2001, 233: 801-7. 10.1097/00000658-200106000-00010.
Barnes Endean ED, SL Kwolek CJ, Minion DJ, Schwarcz TH, Mentzer RM: Surgical management of thrombotic acute intestinal ischemia. Ann Surg. 2001, 233: 801-7. 10.1097/00000658-200106000-00010.
Hyun S, Kim Md, Ajanta Patra MD, Jaward Khan MD, Aravind Arepally MD, Michael B, et al: Transhepatic Catheter-directed Thrombectomy and Thrombolysis of Acute Superior Mesenteric Venous Thrombosis. J Vasc Interv Radiol. 2005, 16: 1685-91.
Kaplan Jonathan L, Weintraub Sharon L, Hunt John P, Gonzales Arturo, Lopera Jorge, Brazzini Augusto: Treatment of Superior Mesenteric and Portal Vein Thrombosis with Direct Thrombolytic Infusion via an Operatively Placed Mesenteric Catheter. Annual Scientific Meeting and Postgraduate Course Program, Southeastern Surgical Congress. 2004, Atlanta, GA
About this article
Cite this article
Milone, M., Di Minno, G., Di Minno, M. et al. Effectiveness of endovascular thrombolysis in acute mesenteric vein thrombosis. BMC Geriatr 11, A35 (2011). https://doi.org/10.1186/1471-2318-11-S1-A35
- Portal Hypertension
- Bowel Resection
- Oral Anticoagulation
- Mesenteric Ischemia
- Bowel Ischemia